 | • レポートコード：QFJ1-5998 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ロミプロスティムの市場動向 ・企業の競争状況、市場シェア ・ロミプロスティムの種類別市場規模と予測2016-2027（250μg/ 0.5mL、500μg/ 1mL） ・ロミプロスティムの用途別市場規模と予測2016-2027（成人、小児患者） ・ロミプロスティムの北米市場規模2016-2027（アメリカ、カナダ） ・ロミプロスティムの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ロミプロスティムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ロミプロスティムの中南米市場規模2016-2027（メキシコ、ブラジル） ・ロミプロスティムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AMGEN） ・結論 |
Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.
Market Analysis and Insights: Global Romiplostim Market
The global Romiplostim market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Romiplostim market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Romiplostim market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Romiplostim market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Romiplostim market.
Global Romiplostim Scope and Market Size
Romiplostim market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Romiplostim market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
250 μg/0.5 mL
500 μg/1 mL
Segment by Application
Adults
Pediatric patients
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AMGEN
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Romiplostim Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 250 μg/0.5 mL
1.2.3 500 μg/1 mL
1.3 Market by Application
1.3.1 Global Romiplostim Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Romiplostim Market Perspective (2016-2027)
2.2 Romiplostim Growth Trends by Regions
2.2.1 Romiplostim Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Romiplostim Historic Market Share by Regions (2016-2021)
2.2.3 Romiplostim Forecasted Market Size by Regions (2022-2027)
2.3 Romiplostim Industry Dynamic
2.3.1 Romiplostim Market Trends
2.3.2 Romiplostim Market Drivers
2.3.3 Romiplostim Market Challenges
2.3.4 Romiplostim Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Romiplostim Players by Revenue
3.1.1 Global Top Romiplostim Players by Revenue (2016-2021)
3.1.2 Global Romiplostim Revenue Market Share by Players (2016-2021)
3.2 Global Romiplostim Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Romiplostim Revenue
3.4 Global Romiplostim Market Concentration Ratio
3.4.1 Global Romiplostim Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Romiplostim Revenue in 2020
3.5 Romiplostim Key Players Head office and Area Served
3.6 Key Players Romiplostim Product Solution and Service
3.7 Date of Enter into Romiplostim Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Romiplostim Breakdown Data by Type
4.1 Global Romiplostim Historic Market Size by Type (2016-2021)
4.2 Global Romiplostim Forecasted Market Size by Type (2022-2027)
5 Romiplostim Breakdown Data by Application
5.1 Global Romiplostim Historic Market Size by Application (2016-2021)
5.2 Global Romiplostim Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Romiplostim Market Size (2016-2027)
6.2 North America Romiplostim Market Size by Type
6.2.1 North America Romiplostim Market Size by Type (2016-2021)
6.2.2 North America Romiplostim Market Size by Type (2022-2027)
6.2.3 North America Romiplostim Market Size by Type (2016-2027)
6.3 North America Romiplostim Market Size by Application
6.3.1 North America Romiplostim Market Size by Application (2016-2021)
6.3.2 North America Romiplostim Market Size by Application (2022-2027)
6.3.3 North America Romiplostim Market Size by Application (2016-2027)
6.4 North America Romiplostim Market Size by Country
6.4.1 North America Romiplostim Market Size by Country (2016-2021)
6.4.2 North America Romiplostim Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Romiplostim Market Size (2016-2027)
7.2 Europe Romiplostim Market Size by Type
7.2.1 Europe Romiplostim Market Size by Type (2016-2021)
7.2.2 Europe Romiplostim Market Size by Type (2022-2027)
7.2.3 Europe Romiplostim Market Size by Type (2016-2027)
7.3 Europe Romiplostim Market Size by Application
7.3.1 Europe Romiplostim Market Size by Application (2016-2021)
7.3.2 Europe Romiplostim Market Size by Application (2022-2027)
7.3.3 Europe Romiplostim Market Size by Application (2016-2027)
7.4 Europe Romiplostim Market Size by Country
7.4.1 Europe Romiplostim Market Size by Country (2016-2021)
7.4.2 Europe Romiplostim Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Romiplostim Market Size (2016-2027)
8.2 Asia-Pacific Romiplostim Market Size by Type
8.2.1 Asia-Pacific Romiplostim Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Romiplostim Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Romiplostim Market Size by Type (2016-2027)
8.3 Asia-Pacific Romiplostim Market Size by Application
8.3.1 Asia-Pacific Romiplostim Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Romiplostim Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Romiplostim Market Size by Application (2016-2027)
8.4 Asia-Pacific Romiplostim Market Size by Region
8.4.1 Asia-Pacific Romiplostim Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Romiplostim Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Romiplostim Market Size (2016-2027)
9.2 Latin America Romiplostim Market Size by Type
9.2.1 Latin America Romiplostim Market Size by Type (2016-2021)
9.2.2 Latin America Romiplostim Market Size by Type (2022-2027)
9.2.3 Latin America Romiplostim Market Size by Type (2016-2027)
9.3 Latin America Romiplostim Market Size by Application
9.3.1 Latin America Romiplostim Market Size by Application (2016-2021)
9.3.2 Latin America Romiplostim Market Size by Application (2022-2027)
9.3.3 Latin America Romiplostim Market Size by Application (2016-2027)
9.4 Latin America Romiplostim Market Size by Country
9.4.1 Latin America Romiplostim Market Size by Country (2016-2021)
9.4.2 Latin America Romiplostim Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Romiplostim Market Size (2016-2027)
10.2 Middle East & Africa Romiplostim Market Size by Type
10.2.1 Middle East & Africa Romiplostim Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Romiplostim Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Romiplostim Market Size by Type (2016-2027)
10.3 Middle East & Africa Romiplostim Market Size by Application
10.3.1 Middle East & Africa Romiplostim Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Romiplostim Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Romiplostim Market Size by Application (2016-2027)
10.4 Middle East & Africa Romiplostim Market Size by Country
10.4.1 Middle East & Africa Romiplostim Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Romiplostim Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AMGEN
11.1.1 AMGEN Company Details
11.1.2 AMGEN Business Overview
11.1.3 AMGEN Romiplostim Introduction
11.1.4 AMGEN Revenue in Romiplostim Business (2016-2021)
11.1.5 AMGEN Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Romiplostim Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 250 μg/0.5 mL
Table 3. Key Players of 500 μg/1 mL
Table 4. Global Romiplostim Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Romiplostim Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Romiplostim Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Romiplostim Market Share by Regions (2016-2021)
Table 8. Global Romiplostim Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Romiplostim Market Share by Regions (2022-2027)
Table 10. Romiplostim Market Trends
Table 11. Romiplostim Market Drivers
Table 12. Romiplostim Market Challenges
Table 13. Romiplostim Market Restraints
Table 14. Global Romiplostim Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Romiplostim Market Share by Players (2016-2021)
Table 16. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Romiplostim as of 2020)
Table 17. Ranking of Global Top Romiplostim Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Romiplostim Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Romiplostim Product Solution and Service
Table 21. Date of Enter into Romiplostim Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Romiplostim Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Romiplostim Revenue Market Share by Type (2016-2021)
Table 25. Global Romiplostim Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Romiplostim Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Romiplostim Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Romiplostim Revenue Market Share by Application (2016-2021)
Table 29. Global Romiplostim Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Romiplostim Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Romiplostim Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Romiplostim Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Romiplostim Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Romiplostim Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Romiplostim Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Romiplostim Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Romiplostim Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Romiplostim Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Romiplostim Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Romiplostim Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Romiplostim Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Romiplostim Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Romiplostim Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Romiplostim Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Romiplostim Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Romiplostim Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Romiplostim Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Romiplostim Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Romiplostim Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Romiplostim Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Romiplostim Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Romiplostim Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Romiplostim Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Romiplostim Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Romiplostim Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Romiplostim Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Romiplostim Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Romiplostim Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Romiplostim Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Romiplostim Market Size by Country (2022-2027) & (US$ Million)
Table 61. AMGEN Company Details
Table 62. AMGEN Business Overview
Table 63. AMGEN Romiplostim Product
Table 64. AMGEN Revenue in Romiplostim Business (2016-2021) & (US$ Million)
Table 65. AMGEN Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Romiplostim Market Share by Type: 2020 VS 2027
Figure 2. 250 μg/0.5 mL Features
Figure 3. 500 μg/1 mL Features
Figure 4. Global Romiplostim Market Share by Application: 2020 VS 2027
Figure 5. Adults Case Studies
Figure 6. Pediatric patients Case Studies
Figure 7. Romiplostim Report Years Considered
Figure 8. Global Romiplostim Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Romiplostim Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Romiplostim Market Share by Regions: 2020 VS 2027
Figure 11. Global Romiplostim Market Share by Regions (2022-2027)
Figure 12. Global Romiplostim Market Share by Players in 2020
Figure 13. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Romiplostim as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Romiplostim Revenue in 2020
Figure 15. Global Romiplostim Revenue Market Share by Type (2016-2021)
Figure 16. Global Romiplostim Revenue Market Share by Type (2022-2027)
Figure 17. North America Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Romiplostim Market Share by Type (2016-2027)
Figure 19. North America Romiplostim Market Share by Application (2016-2027)
Figure 20. North America Romiplostim Market Share by Country (2016-2027)
Figure 21. United States Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Romiplostim Market Share by Type (2016-2027)
Figure 25. Europe Romiplostim Market Share by Application (2016-2027)
Figure 26. Europe Romiplostim Market Share by Country (2016-2027)
Figure 27. Germany Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Romiplostim Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Romiplostim Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Romiplostim Market Share by Region (2016-2027)
Figure 37. China Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Romiplostim Market Share by Type (2016-2027)
Figure 45. Latin America Romiplostim Market Share by Application (2016-2027)
Figure 46. Latin America Romiplostim Market Share by Country (2016-2027)
Figure 47. Mexico Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Romiplostim Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Romiplostim Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Romiplostim Market Share by Country (2016-2027)
Figure 53. Turkey Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Romiplostim Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AMGEN Revenue Growth Rate in Romiplostim Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
世界のトロンボポエチン受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thrombopoietin Receptor Market The global Thrombopoietin Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…- 世界の小児硝子体手術市場規模・現状・予測（2021年-2027年） Vitrectomy is the surgery performed to remove vitreous gel from the middle part of the eye. Market Analysis and Insights: Global Pediatric Vitrectomy Market The global Pediatric Vitrectomy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
- 世界のエトラビリン市場規模・現状・予測（2021年-2027年） Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…
- 世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年） Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF Market Analysis and Insights: Global Pediatric HIV Infection Treatment Market The global Pediatric HIV Infection Treatment market size i…
- 世界の小児灌流システム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Perfusion System Market The global Pediatric Perfusion System market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …